Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors
Drug Development Research · 2026-11 · 87 (7)
DOI: 10.1002/ddr.70382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 14.09.2026. Verfasst von Muhammed Oğuzhan Doğan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Hydrazones, Trimetazidine. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disease, and cholinergic dysfunction is considered one of the fundamental pathological factors of this disease. Guided by the clinically used acetylcholinesterase (AChE) inhibitor donepezil, we explored trimetazidine dihydrochloride as an accessible starting scaffold to generate donepezil‐like features and to develop new anti‐AD candidates. Accordingly, 20 novel hydrazone derivatives were designed and synthesized based on trimetazidine dihydrochloride, and their structures were confirmed by spectroscopic methods. The compounds were evaluated for in vitro inhibition of AChE and butyrylcholinesterase (BChE) using donepezil and tacrine as reference inhibitors, respectively. Several derivatives displayed pronounced AChE inhibition, whereas most compounds showed weak or negligible activity toward BChE, indicating a generally favorable AChE‐selective profile. Among the series, compounds 3p , 3q and 3r exhibited selective inhibitory activity against AChE comparable to donepezil, with IC 50 values of 0.030 ± 0.001 μM, 0.085 ± 0.003 μM and 0.034 ± 0.001 μM, respectively. To rationalize the observed activity trends, molecular docking studies were performed, suggesting that the most active ligands adopt donepezil‐like binding modes spanning the catalytic and peripheral anionic sites and are further stabilized by π–π/π–cation contacts and hydrogen‐bonding interactions within the active gorge. Overall, these findings identify trimetazidine‐derived hydrazide‐hydrazones as a promising chemotype for the development of selective AChE inhibitors and provide a basis for further optimization and advanced biological validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Türkiye.
- Department of Pharmaceutical Chemistry, Institute of Health Sciences, Marmara University, İstanbul, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
- Central Research Laboratory (MERLAB), Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, Eskişehir, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul Aydin University, İstanbul, Türkiye.
ORCID-Profile: Muhammed Oğuzhan Doğan, Begüm Nurpelin Sağlık Özkan, Abdullah Burak Karaduman, Sevgi Karakuş, Zafer Asım Kaplancıklı, Fatih Tok
Förderung
- Scientific and Technological Research Council of Turkey
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Zitieren
APA
Doğan, M. O., Özkan, B. N. S., Karaduman, A. B., Karakuş, S., Özkay, Y., Kaplancıklı, Z. A., & Tok, F. (2026). Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70382
Vancouver
Doğan MO, Özkan BNS, Karaduman AB, Karakuş S, Özkay Y, Kaplancıklı ZA, et al. Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70382
BibTeX
@article{Doan2026,
author = {Doğan, Muhammed Oğuzhan and Özkan, Begüm Nurpelin Sağlık and Karaduman, Abdullah Burak and Karakuş, Sevgi and Özkay, Yusuf and Kaplancıklı, Zafer Asım and Tok, Fatih},
title = {Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {7},
doi = {10.1002/ddr.70382}
}
EUVIMED